
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $10.2M | -- | -- | -$0.07 | -- |
08/29/2025 | Q2 | $8.5M | -- | -- | -$0.11 | -- |
05/15/2025 | Q1 | $7.8M | $7.9M | -$0.13 | -$0.12 | -$0.01 |
03/31/2025 | Q4 | $7.2M | $7.3M | -$0.17 | -$0.12 | -$0.05 |
11/25/2024 | Q3 | $6.7M | $6.5M | -$0.16 | -$0.05 | -$0.11 |
06/30/2024 | Q2 | $6M | $6M | -$0.04 | -$0.10 | $0.06 |
03/31/2024 | Q1 | -- | $5.3M | -$0.48 | -- | -- |
12/31/2023 | Q4 | -- | $4.5M | -$0.53 | -- | -- |
09/30/2023 | Q3 | -- | $3.2M | -$0.13 | -- | -- |
06/30/2023 | Q2 | -- | $2.8M | -$0.21 | -- | -- |
03/31/2023 | Q1 | -- | $2.2M | -$0.06 | -- | -- |
12/31/2022 | Q4 | -- | $2.4M | -- | -- | -- |
09/30/2022 | Q3 | -- | $1.5M | -$0.35 | -- | -- |
06/30/2022 | Q2 | -- | $838K | -$0.35 | -- | -- |
03/31/2022 | Q1 | -- | $699K | -$0.16 | -- | -- |
12/31/2021 | Q4 | -- | $730K | -- | -- | -- |
09/30/2021 | Q3 | -- | $644K | -$0.35 | -- | -- |
06/30/2021 | Q2 | -- | $415K | $0.14 | -- | -- |
03/31/2021 | Q1 | -- | $313K | -$0.70 | -- | -- |
12/31/2020 | Q4 | -- | $262K | -$0.31 | -- | -- |
09/30/2020 | Q3 | -- | $53K | -$0.15 | -- | -- |
06/30/2020 | Q2 | -- | $39K | -$0.13 | -- | -- |
03/31/2020 | Q1 | -- | $42K | -$0.09 | -- | -- |
01/31/2020 | Q1 | -- | -- | -$0.35 | -- | -- |
10/31/2019 | Q4 | -- | -- | -$0.35 | -- | -- |
07/31/2019 | Q3 | -- | -- | -$0.04 | -- | -- |
04/30/2019 | Q2 | -- | -- | $0.33 | -- | -- |
01/31/2019 | Q1 | -- | -- | -$0.70 | -- | -- |
10/31/2018 | Q4 | -- | -- | -$4.24 | -- | -- |
07/31/2018 | Q3 | -- | -- | -$0.03 | -- | -- |
04/30/2018 | Q2 | -- | -- | $0.01 | -- | -- |
01/31/2018 | Q1 | -- | -- | -$0.04 | -- | -- |
10/31/2017 | Q4 | -- | -- | -$0.09 | -- | -- |
07/31/2017 | Q3 | -- | -- | -$0.07 | -- | -- |
04/30/2017 | Q2 | -- | -- | $0.01 | -- | -- |
01/31/2017 | Q1 | -- | -- | -$0.04 | -- | -- |
10/31/2016 | Q4 | -- | -- | -$0.07 | -- | -- |
07/31/2016 | Q3 | -- | -- | -$0.06 | -- | -- |
04/30/2016 | Q2 | -- | -- | -$0.31 | -- | -- |
01/31/2016 | Q1 | -- | -- | -$0.25 | -- | -- |
10/31/2015 | Q4 | -- | -- | -$0.27 | -- | -- |
07/31/2015 | Q3 | -- | -- | -$0.07 | -- | -- |
BioHarvest Sciences reported $7.9M worth of top line sales in its most recent quarter.
BioHarvest Sciences announced earnings per share of -$0.13 which represents a miss of analyst forecast a -$0.12 per share.
BioHarvest Sciences reported $4.6M that represents $0.27 per share over the last quarter.
BioHarvest Sciences's earnings are forecast to decrease from -$0.80 per share to -$0.78 per share next year representing a decrease of -55.94%.
BioHarvest Sciences's next earnings date is August 29, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.